Article thumbnail

Activation of Multiple Apoptotic Pathways in Human Nasopharyngeal Carcinoma Cells by the Prenylated Isoflavone, Osajin

By Tsung-Teng Huang, Fu-Guo Liu, Chia-Fong Wei, Chia-Chen Lu, Chang-Chieh Chen, Hung-Chi Lin, David M. Ojcius and Hsin-Chih Lai

Abstract

Osajin is a prenylated isoflavone showing antitumor activity in different tumor cell lines. The underlying mechanism of osajin-induced cancer cell death is not clearly understood. In the present study, the mechanisms of osajin-induced cell death of human nasopharyngeal carcinoma (NPC) cells were explored. Osajin was found to significantly induce apoptosis of NPC cells in a dose- and time-dependent manner. Multiple molecular effects were observed during osajin treatment including a significant loss of mitochondrial transmembrane potential, release of cytochrome c into the cytosol, enhanced expression of Fas ligand (FasL), suppression of glucose-regulated protein 78 kDa (GRP78), and activation of caspases-9, -8, -4 and -3. In addition, up-regulation of proapoptotic Bax protein and down-regulation of antiapoptotic Bcl-2 protein were also observed. Taken together, osajin induces apoptosis in human NPC cells through multiple apoptotic pathways, including the extrinsic death receptor pathway, and intrinsic pathways relying on mitochondria and endoplasmic reticulum stress. Thus, osajin could be developed as a new effective and chemopreventive compound for human NPC

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3075243
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids.
  2. (1997). Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro.
  3. (2003). Antioxidant isoflavones in Osage orange,
  4. (2004). Antioxidative and EROD activities of osajin and pomiferin.
  5. (1999). Antiproliferative activity of flavonoids on several cancer cell lines.
  6. (1997). Apoptosis by death factor.
  7. (2007). Apoptosis by dietary factors: the suicide solution for delaying cancer growth.
  8. (1999). Apoptosis control by death and decoy receptors.
  9. (2000). Apoptosis in cancer.
  10. (1995). Apoptosis in the pathogenesis and treatment of disease.
  11. (2001). Cakmak A
  12. (2003). Cancer of the nasopharynx.
  13. (2004). Cancer prevention by antioxidants.
  14. (1997). Caspases: intracellular signaling by proteolysis.
  15. (1998). Cell suicide for beginners.
  16. (1993). Characterization of seven newly established nasopharyngeal carcinoma cell lines.
  17. (1998). Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.
  18. (2004). Coupling endoplasmic reticulum stress to the cell death program.
  19. (2008). Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.
  20. (2000). Cross-talk in cell death signaling.
  21. (2008). Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1.
  22. (2006). Effects of prenylated isoflavones osajin and pomiferin in premedication on heart ischemiareperfusion. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150:
  23. (2003). Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation.
  24. (2006). Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurogeneration in INCL.
  25. (1989). Establishment and characterization of a tumor cell line from human nasopharyngeal carcinoma tissue.
  26. (1990). Establishment and characterization of two nasopharyngeal carcinoma cell lines.
  27. (2004). Focus on nasopharyngeal carcinoma.
  28. (2001). Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state.
  29. (2007). GRP78 induction in cancer: therapeutic and prognostic implications.
  30. (2002). Human caspase 12 has acquired deleterious mutations.
  31. (2004). Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis in Abeta-induced cell death.
  32. (2001). Life-or-death decisions by the Bcl-2 family.
  33. (1995). Metalloprotease-mediated release of human Fas ligand.
  34. (1998). Mitochondria and apoptosis.
  35. (2006). Molecular targets of dietary agents for prevention and therapy of cancer.
  36. (2003). Nasopharyngeal carcinoma: an update.
  37. (2007). Nasopharynx cancer: therapeutic value of chemoradiotherapy.
  38. (2002). Negative correlation between the ratio of Bax and Bcl-2 and the size of tumor treated by culture supernatants from Kupffer cells.
  39. (2001). Organelle-specific initiation of cell death pathways.
  40. (2006). Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL.
  41. (2007). Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera.
  42. (2005). Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells.
  43. (1995). Protease activation during apoptosis: death by a thousand cuts? Cell 82: 349–352. Osajin Induces Apoptosis of
  44. (1996). Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153).
  45. (2002). Spontaneous and drug-induced apoptosis is mediated apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia.
  46. (2006). Stress induction of GRP78/BiP and its role in cancer.
  47. (1999). Stress singling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls.
  48. (2002). Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.
  49. (2002). Studies of apoptosis and bcl-2 in experimental atherosclerosis in rabbit and influence of selenium supplementation.
  50. (1997). The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry.
  51. (2002). The biochemistry and medical significance of the flavonoids.
  52. (2000). Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction.